Authors: Gleave, ME Miyake, H Zellweger, T Chi, K July, L Nelson, C Rennie, P

Citation: Me. Gleave et al., Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer, UROLOGY, 58(2A), 2001, pp. 39-48

Authors: Gleave, ME Miyake, H Nelson, C Rennie, P Leung, S

Citation: Me. Gleave et al., Targeting antiapoptotic genes upregulated by androgen withdrawal using antisense oligodeoxynucleotides to enhance androgen-and chemo-sensitivity in prostate cancer, CONT CANC R, 2001, pp. 327-340

Authors: Gleave, M Goldenberg, SL Bruchovsky, N Rennie, P

Citation: M. Gleave et al., Intermittent androgen suppression for prostate cancer: rationale and clinical experience, PROSTATE C, 1(6), 1998, pp. 289-296